IBX 8.20% 5.6¢ imagion biosystems limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-32

  1. 127 Posts.
    lightbulb Created with Sketch. 27
    A bit frustrated.
    "If patient accessibility continues to be slow, completing enrolment by the end of the year will be difficult".
    So what about Bob said that the trial was on track to complete by end of this year?
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.